Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8203595rdf:typepubmed:Citationlld:pubmed
pubmed-article:8203595lifeskim:mentionsumls-concept:C0031603lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C0039231lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C0149721lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8203595lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:8203595pubmed:issue5 Pt 2lld:pubmed
pubmed-article:8203595pubmed:dateCreated1994-7-5lld:pubmed
pubmed-article:8203595pubmed:abstractTextSpatially localized nuclear magnetic resonance (NMR) spectroscopy was used to examine the effect of tachycardia and inotropic stimulation on myocardial ATP, creatine phosphate (CrP), and inorganic phosphate (Pi) in animals with left ventricular hypertrophy (LVH). Studies were performed in eight normal dogs and seven dogs with moderate LVH produced by banding the ascending aorta. 31P-NMR spectra were obtained from five layers across the LV wall, while blood flow (BF) was measured with microspheres during control conditions, pacing at 200 and 240 beats/min, and during dobutamine infusion (Dob). Myocardial ATP and CrP levels were normal in the LVH hearts during control conditions. Pacing did not alter the transmural distribution of perfusion or the levels of CrP, ATP, and Pi in normal hearts. In contrast, in four of seven LVH hearts, pacing decreased the subendocardial/subepicardial (ENDO/EPI) BF ratio and caused depletion of CrP and appearance of Pi characteristic of ischemia in the subendocardium. Dob produced greater increases in the heart rate x LV systolic pressure product (RPP) and greater increases of Pi and decreases of CrP in LVH than in normal hearts; however, at comparable elevations of RPP the alterations of Pi and CrP were similar in both groups. Although Dob decreased the ENDO/EPI in LVH hearts, Dob-induced alterations in CrP and Pi were uniform across the LV wall. Increasing myocardial BF with adenosine or carbochromen did not reverse the alterations in Pi or CrP produced by Dob. We conclude that 1) ENDO perfusion abnormalities during tachycardia in LVH do produce ENDO subendocardial ischemia; 2) when the degree of augmentation of mechanical performance is considered, the metabolic changes induced by Dob were similar in normal and LVH hearts; 3) Dob-induced alterations in Pi and CrP were not related to inadequate perfusion, since increasing coronary BF did not reverse these changes; and 4) alterations of Pi and CrP during Dob infusion were not more prominent in the ENDO, indicating that the decreased ENDO/EPI flow did not cause ENDO ischemia but may reflect relatively lower O2 demands in this region during inotropic stimulation.lld:pubmed
pubmed-article:8203595pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:languageenglld:pubmed
pubmed-article:8203595pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:citationSubsetIMlld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8203595pubmed:statusMEDLINElld:pubmed
pubmed-article:8203595pubmed:monthMaylld:pubmed
pubmed-article:8203595pubmed:issn0002-9513lld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:UgurbilKKlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:BacheR JRJlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:FromA HAHlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:MerkleHHlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:PattSSlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:ZhangJJlld:pubmed
pubmed-article:8203595pubmed:authorpubmed-author:HendrichKKlld:pubmed
pubmed-article:8203595pubmed:issnTypePrintlld:pubmed
pubmed-article:8203595pubmed:volume266lld:pubmed
pubmed-article:8203595pubmed:ownerNLMlld:pubmed
pubmed-article:8203595pubmed:authorsCompleteYlld:pubmed
pubmed-article:8203595pubmed:paginationH1959-70lld:pubmed
pubmed-article:8203595pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:meshHeadingpubmed-meshheading:8203595-...lld:pubmed
pubmed-article:8203595pubmed:year1994lld:pubmed
pubmed-article:8203595pubmed:articleTitleHigh-energy phosphate responses to tachycardia and inotropic stimulation in left ventricular hypertrophy.lld:pubmed
pubmed-article:8203595pubmed:affiliationDepartment of Medicine, University of Minnesota, Minneapolis 55455.lld:pubmed
pubmed-article:8203595pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8203595pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8203595pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8203595pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8203595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8203595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8203595lld:pubmed